London calling logo

London Calling 2024 - Speakers

Speakers

Subscribe

Check out the line up of speaking at London Calling 2024.

Oxford Nanopore Technologies

Dr. Charles K. Cooper

Charles K Cooper
Job title
Institution
bioMérieux, France
Biography

Dr. Charles K. Cooper is a graduate from Georgetown University School of Medicine (Washington, DC) and specialized in infectious diseases and epidemiology (University of Maryland, Baltimore). He has been practicing medicine for over 25 years and still devotes two days a month to this work.

He was previously Chief Medical Officer at Siemens Healthcare Diagnostics. He also spent eight years as the head of Medical Affairs at Becton Dickinson Diagnostics and 13 years with the U.S. Food & Drug Administration. With this extensive experience in both governmental and private organizations, Dr. Charles K. Cooper is working to address global patients and customers’ needs, helping to improve public health worldwide.

Recent publications

Pekosz, A. et al. Antigen-based testing but not real-time polymerase chain reaction correlates with severe acute respiratory syndrome coronavirus 2 viral culture. Clin. Infect. Dis. 73(9):e2861–e2866 (2021). doi: 10.1093/cid/ciaa1706.

Parvu, V. et al. Factors that influence the reported sensitivity of rapid antigen testing for SARS-CoV-2. Front. Microbiol. 12:714242 (2021). DOI: 10.3389/fmicb.2021.714242

Shah, M, et al. Multicenter study of the accuracy of the BD MAX multidrug-resistant Tuberculosis assay for detection of Mycobacterium tuberculosis complex and mutations associated With resistance to Rifampin and Isoniazid. Clin. Infect. Dis. 71(5):1161–1167. (2020). DOI: 10.1093/cid/ciz932

Talks at this conference

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag